Hypertension management

antihypertensive drugs vs placebo

7 studies (8,985,214 patients) provide low-certainty evidence for benefit of antihypertensive drugs for the outcome in Frailty.

antihypertensive vs placebo

8 studies (5,289,215 patients) provide low-certainty evidence against benefit of antihypertensive for the outcome in Stroke.

angiotensin receptor blockers vs placebo

26 studies (3,889,575 patients) provide low-certainty evidence against benefit of angiotensin receptor blockers for the outcome in Hypertensive disease.

statin vs placebo

13 studies (1,558,581 patients) provide low-certainty evidence against benefit of statin for the outcome in Hypertensive disease.

metoprolol vs propranolol

6 studies (1,051,130 patients) provide low-certainty evidence against benefit of metoprolol for the outcome in Hypertensive disease.

diuretics vs placebo

26 studies (903,774 patients) provide low-certainty evidence against benefit of diuretics for the outcome in Hypertensive disease.

antihypertensives vs placebo · Cardiac Output

452 studies (266,807,266 patients) provide insufficient evidence with mixed findings regarding antihypertensives for Cardiac Output in Hypertensive disease.

angiotensin converting enzyme inhibitor vs angiotensin receptor blocker

10 studies (7,152,153 patients) provide insufficient evidence with mixed findings regarding angiotensin converting enzyme inhibitor for the outcome in Hypertensive disease.

amlodipine vs chlorthalidone

8 studies (136,774 patients) provide insufficient evidence with mixed findings regarding amlodipine for the outcome in Hypertensive disease.

antihypertensive drugs vs diuretic

6 studies (7,903,740 patients) provide insufficient evidence with mixed findings regarding antihypertensive drugs for the outcome in Hypertensive disease.